Evaluating possible improvement in speech and hearing tests after 28 days of dosing of the study drug AUT00063 compared to placebo (QuicKfire)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The objective of this pilot study is to explore whether repeat doses of AUT00063 can provide an indication of improvement in performance of tests across a battery of speech and hearing assessments in cochlear implant users.
Epistemonikos ID: db73acc57fdf47f726153652c867a21670d7e0e2
First added on: May 17, 2024